{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:10:26Z","timestamp":1789071026272,"version":"build-2803163510"},"reference-count":34,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":244,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM146372"],"award-info":[{"award-number":["R01GM146372"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA251600"],"award-info":[{"award-number":["R01CA251600"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HT94252510778"],"award-info":[{"award-number":["HT94252510778"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["F30CA295068"],"award-info":[{"award-number":["F30CA295068"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32GM156735"],"award-info":[{"award-number":["T32GM156735"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32GM008347"],"award-info":[{"award-number":["T32GM008347"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["2237827"],"award-info":[{"award-number":["2237827"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The fetal form of the insulin receptor (IRA) is predominantly expressed in many cancers, where IR signaling promotes progression of the disease. Alternatively, the adult IR isoform (IRB) is predominantly expressed in normal tissues. Previous attempts to target IR indiscriminately via dual IR\/IGF1R tyrosine kinase inhibitors frequently failed due to on-target off-tumor effects. However, an IRA-specific therapeutic has the potential to specifically target cancer while sparing normal tissues. Furthermore, an IRA-specific binder would advance research regarding this disease-associated isoform. Yet, isoform-specific IR binders have not been developed. Herein, we engineer six high-affinity, IRA-specific protein binders from a synthetic miniprotein scaffold. These miniprotein variants have IRA KDs ranging from 0.98\u20137.6\u00a0nM with no appreciable IRB binding at 100\u00a0nM ligand. Five of the six variants are synergistic agonists. One variant (V1) is a passive, IRA-specific binder with a KD\u00a0=\u20096.3\u00a0nM and no IRB binding at 1\u00a0\u03bcM ligand as well as no IGF1R binding at 100\u00a0nM, which provides compelling potential as a targeted therapeutic. Additionally, we present the discovery process for these molecules, a yeast display directed evolution campaign utilizing a combination of sorting techniques. Retrospective analysis of the discovery process revealed the importance of alternating selections for target affinity and isoform specificity to generate binders with a favorable combination of these properties.<\/jats:p>","DOI":"10.1093\/protein\/gzag025","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:50:56Z","timestamp":1788375056000},"source":"Crossref","is-referenced-by-count":0,"title":["Engineering isoform-selective miniprotein binders to the fetal form of the insulin receptor"],"prefix":"10.1093","volume":"39","author":[{"given":"Melissa A","family":"Walsh","sequence":"first","affiliation":[{"name":"Dept. of Biomedical Engineering, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Dept. of Chemical Engineering and Materials Science, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel T","family":"Cheung","sequence":"additional","affiliation":[{"name":"Dept. of Chemical Engineering and Materials Science, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-4009","authenticated-orcid":false,"given":"Douglas","family":"Yee","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]},{"name":"Dept. of Pharmacology, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-9463","authenticated-orcid":false,"given":"Benjamin J","family":"Hackel","sequence":"additional","affiliation":[{"name":"Dept. of Biomedical Engineering, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]},{"name":"Dept. of Chemical Engineering and Materials Science, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]},{"name":"Masonic Cancer Center, University of Minnesota , Minneapolis, MN, 55455 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"2026091015463746100_ref1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"2026091015463746100_ref2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: From mechanism to clinical studies","volume":"8","author":"","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026091015463746100_ref3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/er.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: An updated view","volume":"38","author":"Belfiore","year":"2017","journal-title":"Endocr Rev"},{"key":"2026091015463746100_ref4","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1021\/acssynbio.3c00409","article-title":"Hyperstable synthetic mini-proteins as effective ligand scaffolds","volume":"12","author":"Blanchard","year":"2023","journal-title":"ACS Synth Biol"},{"key":"2026091015463746100_ref5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fendo.2015.00077","article-title":"The role of the insulin\/IGF system in cancer: Lessons learned from clinical trials and the energy balance-cancer link","volume":"6","author":"Bowers","year":"2015","journal-title":"Front Endocrinol"},{"key":"2026091015463746100_ref6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/ijms22020555","article-title":"Disrupting insulin and IGF receptor function in cancer","volume":"22","author":"Cao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026091015463746100_ref7","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1158\/1535-7163.MCT-16-0685","article-title":"Targeting insulin receptor in breast cancer using small engineered protein scaffolds","volume":"16","author":"Chan","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"2026091015463746100_ref8","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1158\/0008-5472.CAN-12-0684","article-title":"Acquired resistance to tamoxifen is associated with loss of the type I insulin-like growth factor receptor: Implications for breast cancer treatment","volume":"72","author":"Fagan","year":"2012","journal-title":"Cancer Res"},{"key":"2026091015463746100_ref9","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/1541-7786.MCR-15-0279","article-title":"Intrinsic resistance to Cixutumumab is conferred by distinct isoforms of the insulin receptor","volume":"13","author":"Forest","year":"2015","journal-title":"Molecular Cancer Research"},{"key":"2026091015463746100_ref10","doi-asserted-by":"publisher","first-page":"15006","DOI":"10.3390\/ijms241915006","article-title":"Insulin receptor isoforms and insulin growth factor-like receptors: Implications in cell signaling, carcinogenesis, and chemoresistance","volume":"24","author":"Galal","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026091015463746100_ref11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/14712598.2022.2040987","article-title":"The evolution of bispecific antibodies","volume":"22","author":"Gera","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"2026091015463746100_ref12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/antib14010016","article-title":"Immune cell engagers: Advancing precision immunotherapy for cancer treatment","volume":"14","author":"In","year":"2025","journal-title":"Antibodies"},{"key":"2026091015463746100_ref13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fendo.2017.00167","article-title":"Structural perspectives of insulin receptor isoform-selective insulin Analogs","volume":"8","author":"Jir\u00e1\u010dek","year":"2017","journal-title":"Front Endocrinol"},{"key":"2026091015463746100_ref14","doi-asserted-by":"publisher","first-page":"T187","DOI":"10.1530\/JME-18-0076","article-title":"40 YEARS of IGF1: Understanding the tissue-specific roles of IGF1\/IGF1R in regulating metabolism using the Cre\/loxP system","volume":"61","author":"Kineman","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"2026091015463746100_ref15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2967\/jnumed.117.199901","article-title":"Same-day imaging using small proteins: Clinical experience and translational prospects in oncology","volume":"59","author":"Krasniqi","year":"2018","journal-title":"J Nucl Med"},{"key":"2026091015463746100_ref16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"2026091015463746100_ref17","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1802.03426","article-title":"UMAP: Uniform manifold approximation and projection for dimension reduction","author":"McInnes","year":"2020"},{"key":"2026091015463746100_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113862","article-title":"Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells","volume":"434","author":"Monteiro","year":"2024","journal-title":"Exp Cell Res"},{"key":"2026091015463746100_ref19","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.103036","volume-title":"Evolving Concepts in Insulin Resistance","author":"Moruzzi","year":"2022"},{"key":"2026091015463746100_ref20","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3390\/cancers13163949","article-title":"The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: An updated review","volume":"13","author":"Rascio","year":"2021","journal-title":"Cancers"},{"key":"2026091015463746100_ref21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1126\/science.aan0693","article-title":"Global analysis of protein folding using massively parallel design, synthesis, and testing","volume":"357","author":"Rocklin","year":"2017","journal-title":"Science"},{"key":"2026091015463746100_ref22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41423-024-01176-4","article-title":"Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases","volume":"21","author":"Rolin","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"2026091015463746100_ref23","doi-asserted-by":"publisher","first-page":"7496","DOI":"10.3390\/ijms21207496","article-title":"Toward drug-like multispecific antibodies by design","volume":"21","author":"Sawant","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026091015463746100_ref24","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1158\/1535-7163.MCT-09-0195","article-title":"A Modeling analysis of the effects of molecular size and binding affinity on tumor targeting","volume":"8","author":"Schmidt","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"2026091015463746100_ref25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/cr800373w","article-title":"Fundamental aspects of protein\u2212protein association kinetics","volume":"109","author":"Schreiber","year":"2009","journal-title":"Chem Rev"},{"key":"2026091015463746100_ref26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3858\/emm.2011.43.10.063","article-title":"One target, different effects: A comparison of distinct therapeutic antibodies against the same targets","volume":"43","author":"Shim","year":"2011","journal-title":"Exp Mol Med"},{"key":"2026091015463746100_ref27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/acscombsci.6b00191","article-title":"Titratable avidity reduction enhances affinity discrimination in mammalian cellular selections of yeast-displayed ligands","volume":"19","author":"Stern","year":"2017","journal-title":"ACS Comb Sci"},{"key":"2026091015463746100_ref28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-1-4939-9853-1_17","article-title":"Ligand engineering via yeast surface display and adherent cell panning","volume":"2070","author":"Stern","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2026091015463746100_ref29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1021\/acscombsci.8b00156","article-title":"Cellular-based selections aid yeast-display discovery of genuine cell-binding ligands: Targeting oncology vascular biomarker CD276","volume":"21","author":"Stern","year":"2019","journal-title":"ACS Comb Sci"},{"key":"2026091015463746100_ref30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/abt\/tbae007","article-title":"Structure and function of therapeutic antibodies approved by the US FDA in 2023","volume":"7","author":"Strohl","year":"2024","journal-title":"Antib Ther"},{"key":"2026091015463746100_ref31","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.addr.2008.04.012","article-title":"Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance","volume":"60","author":"Thurber","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"2026091015463746100_ref32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymeth.2012.03.010","article-title":"Cells and cell lysates: A direct approach for engineering antibodies against membrane proteins using yeast surface display","volume":"60","author":"Tillotson","year":"2013","journal-title":"Methods"},{"key":"2026091015463746100_ref33","first-page":"255","volume-title":"Methods in Enzymology","author":"Wittrup","year":"2012"},{"key":"2026091015463746100_ref34","volume-title":"Quantitative Fundamentals of Molecular and Cellular Bioengineering","author":"Wittrup","year":"2019"}],"container-title":["Protein Engineering, Design and Selection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/peds\/advance-article-pdf\/doi\/10.1093\/protein\/gzag025\/70925338\/gzag025.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/peds\/article-pdf\/doi\/10.1093\/protein\/gzag025\/70925338\/gzag025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/peds\/article-pdf\/doi\/10.1093\/protein\/gzag025\/70925338\/gzag025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:46:43Z","timestamp":1789069603000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/peds\/article\/doi\/10.1093\/protein\/gzag025\/8780321"}},"subtitle":[],"editor":[{"given":"Arne","family":"Skerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1093\/protein\/gzag025","relation":{},"ISSN":["1741-0126","1741-0134"],"issn-type":[{"value":"1741-0126","type":"print"},{"value":"1741-0134","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"gzag025"}}